Pallas Capital Advisors LLC Nuvation Bio Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 17,016 shares of NUVB stock, worth $33,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,016
Previous 15,934
6.79%
Holding current value
$33,521
Previous $36,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
151MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$51.1 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$31 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$25.8 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$18.1 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $428M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...